Disease Info Card

Mobility Limitation

Information about Mobility Limitation: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Mobility Limitation

Most recent studies have shown that Mobility Limitation shares some biological mechanisms with arthritis, cerebral-palsy, cerebrovascular-accident, cognition-disorders, degenerative-polyarthritis, dementia, depressive-disorder, diabetes-mellitus, fracture, gait-disorders-neurologic, hip-fractures, impaired-cognition, impairment-(finding), malignant-neoplasms, multiple-sclerosis, obesity, osteoarthritis-knee, pain, sclerosis, spinal-cord-injuries.

Among the many pathways, these few ones have gauged particular interests from scientists studying Mobility Limitation, and have been seen in publications frequently: Aging, Coagulation, Cognition, Excretion, Flight, Glomerular Filtration, Hypersensitivity, Innervation, Locomotion, Menopause, Muscle Atrophy, Muscle Hypertrophy, Ossification, Pathogenesis, Platelet Activation, Proprioception, Reflex, Translation, Transport, Wound Healing

Quite a number of genes have been found to play important roles in Mobility Limitation, such as ABCB6, ALB, ASPSCR1, BBS2, BEST1, BLOC1S6, CP, CRP, DMD, DNMT3B, FUT2, GRIP1, IL6, NDUFB6, SGCA, SQLE, TNF, ZMYM2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.